Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9EBZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,934
Award facts
- Contract value 100% obligated
- $24,934.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $24,934 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Skyrizi 360 mg/2.4 mL on-body 2.4 mL injectable medication. This is a non-set-aside, competitively awarded contract with an ultimate completion date of February 23, 2026. The contract will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (formerly Amerisourcebergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. Through this contract structure, Amerisourcebergen supplies critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating the company's significant role in the government's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9EBZ?
SPE2DR26F9EBZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9EBZ worth?
The government has obligated $24,934 on SPE2DR26F9EBZ.
Is contract SPE2DR26F9EBZ an order under another contract?
Yes. SPE2DR26F9EBZ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EBZ competed?
The extent of competition for SPE2DR26F9EBZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award